The project titled: “Synthetic peptides targeting METTL13 as novel therapeutics for diffuse midline glioma” will focus on creating molecules called synthetic peptides that are designed to specifically block a protein in DIPG/DMG cancer cells. Peptides could potentially stop disease progression by interfering with cancer cell function and growth. The project aim is to create safer and more effective therapies to improve survival rates and chance quality of life for children battling brain cancer. The location of the cancer and the ineffectiveness of current therapies continue to challenge the medical community. The project is a hopeful step forward in the fight against pediatric brain cancer. 

This grant is made possible through the extraordinary support of Kayge Fighters Foundation, the DIPG community, and Brain Cancer Canada’s donation match.

Press release available at:   
https://www.globenewswire.com/news-release/2024/12/03/2990829/0/en/Brain-Cancer-Canada-a-leading-advocate-in-the-fight-against-brain-cancer-is-proud-to-award-a-100-000-research-grant-to-one-of-Canada-s-top-neuropathologists-to-support-research-on-.html